Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. It mainly focuses on developing novel medicines to address serious medical conditions for individuals in need of treatment options. The company emphasizes product development efforts in the field of hemostasis and to develop valuable therapies for individuals with hemophilia. It is engaged in the clinical development of improved, next-generation subcutaneous prophylaxis using enhanced potency Factor VIIa and Factor IX variants.
| Last: | $8.24 |
|---|---|
| Change Percent: | -1.67% |
| Open: | $8.1 |
| Close: | $8.38 |
| High: | $8.37 |
| Low: | $8.09 |
| Volume: | 48,693 |
| Last Trade Date Time: | 03/11/2026 12:43:38 pm |
| Market Cap: | $767,775,261 |
|---|---|
| Float: | 71,190,203 |
| Insiders Ownership: | 0.16% |
| Institutions: | 17 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | www.gyretx.com |
| Country: | US |
| City: | San Diego |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Gyre Therapeutics Inc. (NASDAQ: GYRE).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
